Bernadette Ngeno1, Anthony Waruru2, Irene Inwani3, Lucy Nganga2, Evelyn Ngugi Wangari2, Abraham Katana2, Anthony Gichangi2, Ann Mwangi4, Irene Mukui4, George W Rutherford5. 1. Division of Global HIV & TB, US Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: uyt0@cdc.gov. 2. Division of Global HIV & TB, US Centers for Disease Control and Prevention, CDC-Kenya, Nairobi, Kenya. 3. Kenyatta National Hospital, Nairobi, Kenya. 4. National AIDS and STI Control Programme, Ministry of Health, Annex Kenyatta National Hospital Grounds, Nairobi, Kenya. 5. Institute for Global Health Sciences, University of California, San Francisco, San Francisco California.
Abstract
PURPOSE: Informing adolescents of their own HIV infection is critical as the number of adolescents living with HIV increases. We assessed the association between HIV disclosure and retention in care and mortality among adolescents aged 10-14 years in Kenya's national program. METHODS: We abstracted routinely collected patient-level data for adolescents enrolled into HIV care in 50 health facilities from November 1, 2004, through March 31, 2010. We defined disclosure as any documentation that the adolescent had been fully or partially made aware of his or her HIV status. We compared weighted proportions for categorical variables using χ2 and weighted logistic regression to identify predictors of HIV disclosure; we estimated the probability of LTFU using Kaplan-Meier methods and dying using Cox regression-based test for equality of survival curves. RESULTS: Of the 710 adolescents aged 10-14 years analyzed; 51.3% had severe immunosuppression, 60.3% were in WHO stage 3 or 4, and 36.6% were aware of their HIV status. Adolescents with HIV-infected parents, histories of opportunistic infections (OIs), and enrolled in support groups were more likely to be disclosed to. At 36 months, disclosure was associated with lower mortality [1.5% (95% CI .6%-4.1%) versus 5.4% (95% CI 3.6.6%-8.0%, p < .001)] and lower LTFU [6.2% (95% CI 3.0%-12.6%) versus 33.9% (95% CI 27.3%-41.1%) p < .001]. CONCLUSIONS: Only one third of HIV-infected Kenyan adolescents in treatment programs had been told they were infected, and knowing their HIV status was associated with reduced LTFU and mortality. The disclosure process should be systematically encouraged and organized for HIV-infected adolescents.
PURPOSE: Informing adolescents of their own HIV infection is critical as the number of adolescents living with HIV increases. We assessed the association between HIV disclosure and retention in care and mortality among adolescents aged 10-14 years in Kenya's national program. METHODS: We abstracted routinely collected patient-level data for adolescents enrolled into HIV care in 50 health facilities from November 1, 2004, through March 31, 2010. We defined disclosure as any documentation that the adolescent had been fully or partially made aware of his or her HIV status. We compared weighted proportions for categorical variables using χ2 and weighted logistic regression to identify predictors of HIV disclosure; we estimated the probability of LTFU using Kaplan-Meier methods and dying using Cox regression-based test for equality of survival curves. RESULTS: Of the 710 adolescents aged 10-14 years analyzed; 51.3% had severe immunosuppression, 60.3% were in WHO stage 3 or 4, and 36.6% were aware of their HIV status. Adolescents with HIV-infected parents, histories of opportunistic infections (OIs), and enrolled in support groups were more likely to be disclosed to. At 36 months, disclosure was associated with lower mortality [1.5% (95% CI .6%-4.1%) versus 5.4% (95% CI 3.6.6%-8.0%, p < .001)] and lower LTFU [6.2% (95% CI 3.0%-12.6%) versus 33.9% (95% CI 27.3%-41.1%) p < .001]. CONCLUSIONS: Only one third of HIV-infected Kenyan adolescents in treatment programs had been told they were infected, and knowing their HIV status was associated with reduced LTFU and mortality. The disclosure process should be systematically encouraged and organized for HIV-infected adolescents.
Authors: A C Gerson; M Joyner; P Fosarelli; A Butz; L Wissow; S Lee; P Marks; N Hutton Journal: J Pediatr Health Care Date: 2001 Jul-Aug Impact factor: 1.812
Authors: Bernadette Ng'eno; Ann Mwangi; Lucy Ng'ang'a; Andrea A Kim; Anthony Waruru; Irene Mukui; Evelyn W Ngugi; George W Rutherford Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Casey Adams; Millicent Kiruki; Robinson Karuga; Lilian Otiso; Susan M Graham; Kristin M Beima-Sofie Journal: BMC Public Health Date: 2022-06-30 Impact factor: 4.135
Authors: Judith J Toromo; Edith Apondi; Winstone M Nyandiko; Mark Omollo; Salim Bakari; Josephine Aluoch; Rami Kantor; J Dennis Fortenberry; Kara Wools-Kaloustian; Batya Elul; Rachel C Vreeman; Leslie A Enane Journal: BMC Public Health Date: 2022-06-04 Impact factor: 4.135
Authors: Brian C Zanoni; Moherndran Archary; Tamarra Subramony; Thobekile Sibaya; Christina Psaros; Jessica E Haberer Journal: AIDS Behav Date: 2021-01
Authors: Brian C Zanoni; Moherndran Archary; Thobekile Sibaya; Nicholas Musinguzi; Mary E Kelley; Shauna McManus; Jessica E Haberer Journal: J Int AIDS Soc Date: 2021-07 Impact factor: 5.396